1,2-Dipalmitoyl-d6-rac-glycero-3-PC
(Synonyms: 16:0/16:0-d6-PC, PC(16:0/16:0)-d6, 1,2-Dihexadecanoyl-d6-rac-glycero-3-Phosphocholine, 1,2-Dihexadecanoyl-d6-rac-glycero-3-Phosphatidylcholine) 目录号 : GC46043
An internal standard for the quantification of 1,2-dipalmitoyl-rac-glycero-3-PC
Cas No.:82765-17-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
1,2-Dipalmitoyl-d6-rac-glycero-3-PC is intended for use as an internal standard for the quantification of 1,2-dipalmitoyl-rac-glycero-3-PC by GC- or LC-MS. 1,2-Dipalmitoyl-rac-glycero-3-PC is a phosphatidylcholine that contains palmitic acid at the sn-1 and sn-2 positions. It has been used as a component of liposomes, monolayers, and bilayers to study the influence of chirality on membrane dynamics.1,2,3,4 1,2-dipalmitoyl-rac-glycero-3-PC has been used to study electric field-induced orientation of phosphatidylcholine head groups and dynamics of liposomal phase transitions.2,3
|1. Vollhardt, D., Nandi, N., and Banki, S.D. Nanoaggregate shapes at the air/water interface. Phys. Chem. Chem. Phys. 13(11), 4812-4829 (2011).|2. Mishima, K., Tanaka, S., and Ogihara, T. Electric field-induced orientation of L- and DL-phosphatidylcholine bilayers. Biochim. Biophys. Acta. 1565(1), 107-111 (2002).|3. Boyanov, A.I., Tenchov, B.G., Koynova, R.D., et al. Absence of subtransition in racemic dipalmitoylphosphatidylcholine vesicles. Biochim. Biophys. Acta 732, 711-713 (1983).|4. Moy, V.T., Keller, D.J., Gaub, H.E., et al. Long-range molecular orientational order in monolayer solid domains of phospholipid. J. Phys. Chem. 90(14), 3198-3202 (1986).
| Cas No. | 82765-17-1 | SDF | |
| 别名 | 16:0/16:0-d6-PC, PC(16:0/16:0)-d6, 1,2-Dihexadecanoyl-d6-rac-glycero-3-Phosphocholine, 1,2-Dihexadecanoyl-d6-rac-glycero-3-Phosphatidylcholine | ||
| Canonical SMILES | O=C(CCCCCCCCCCCCCCC([2H])([2H])[2H])OCC(OC(CCCCCCCCCCCCCCC([2H])([2H])[2H])=O)COP(OCC[N+](C)(C)C)([O-])=O | ||
| 分子式 | C40H74D6NO8P | 分子量 | 740.1 |
| 溶解度 | Methanol: soluble | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.3512 mL | 6.7558 mL | 13.5117 mL |
| 5 mM | 0.2702 mL | 1.3512 mL | 2.7023 mL |
| 10 mM | 0.1351 mL | 0.6756 mL | 1.3512 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。